Insiders Buy the Holdings of XBI ETF

By
A A A

A look at the weighted underlying holdings of the SPDR S&P Biotech ETF ( XBI ) shows an impressive 11.2% of holdings on a weighted basis have experienced insider buying within the past six months.

Synergy Pharmaceuticals Inc (Symbol: SGYP), which makes up 1.25% of the SPDR S&P Biotech ETF ( XBI ), has seen 4 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $14,105,926 worth of SGYP, making it the #49 largest holding. The table below details the recent insider buying activity observed at SGYP:

SGYP - last trade: $4.17 - Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
05/23/2014 Bernard Denoyer Senior Vice President, Finance 2,500 $3.89 $9,725.00
05/23/2014 Kunwar Shailubhai Chief Scientific Officer 3,000 $3.89 $11,670.00
05/27/2014 Gary S. Jacob Chief Executive Officer 4,000 $4.18 $16,720.00
06/03/2014 John P. Brancaccio Director 3,500 $4.12 $14,420.00


And Merrimack Pharmaceuticals Inc. (Symbol: MACK), the #56 largest holding among components of the SPDR S&P Biotech ETF ( XBI ), shows 6 directors and officers as recently filing Form 4's indicating purchases. The ETF holds $13,945,206 worth of MACK, which represents approximately 1.23% of the ETF's total assets at last check. The recent insider buying activity observed at MACK is detailed in the table below:

MACK - last trade: $7.29 - Recent Insider Buys:

Purchased Insider Title Shares Price/Share Value
05/05/2014 Michael E. Porter Director 15,000 $6.41 $96,150.00
05/05/2014 Gary L. Crocker Director 10,000 $6.69 $66,900.00
05/05/2014 Robert J. Mulroy President and CEO 5,000 $6.31 $31,550.00
05/06/2014 Gary L. Crocker Director 17,500 $6.89 $120,575.00
05/05/2014 Michael E. Porter Director 5,000 $6.12 $30,600.00
05/07/2014 Gary L. Crocker Director 4,400 $6.77 $29,788.00
05/07/2014 Sarah E. Nash Director 15,000 $6.79 $101,850.00
05/08/2014 Michael E. Porter Director 10,000 $6.59 $65,900.00
05/13/2014 Anthony J. Sinskey Director 5,000 $6.74 $33,700.00
05/16/2014 Michael E. Porter Director 15,000 $6.49 $97,400.00
05/19/2014 Gary L. Crocker Director 9,400 $6.68 $62,802.00
05/19/2014 James H. Quigley Director 5,000 $6.58 $32,900.00
05/20/2014 Gary L. Crocker Director 4,000 $6.69 $26,760.00
06/23/2014 Michael E. Porter Director 32,390 $6.84 $221,547.60
06/23/2014 Gary L. Crocker Director 36,000 $6.84 $246,240.00

10 ETFs With Stocks That Insiders Are Buying »



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: Investing , ETFs

Referenced Stocks: XBI , SGYP , MACK

BNK Invest

BNK Invest

More from BNK Invest:

Related Videos

Top Home Financing Myths
Top Home Financing Myths            

Stocks

Referenced

Most Active by Volume

64,655,493
  • $17.88 ▼ 1.38%
53,363,101
  • $18.51 ▼ 6.98%
42,789,793
  • $94.01 ▼ 1.26%
40,818,762
  • $121.30 ▼ 0.87%
38,086,152
  • $23.28 ▼ 9.17%
36,103,930
  • $14.20 ▼ 0.77%
31,870,696
  • $14.83 ▼ 1.79%
29,019,850
  • $46.70 ▼ 0.38%
As of 7/31/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com